Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA studyIdanna Innocenti, Luca Laurenti, Marina Deodato et al.|Haematologica|2022Cited by 20
Long‐term benefit of IGHV mutated patients in a real‐life multicenter cohort of FCR‐treated chronic lymphocytic leukemiaRiccardo Moia, Gianluca Gaïdano, Riccardo Dondolin et al.|Hematological Oncology|2022Cited by 4
Comparison of Familial Versus Sporadic Forms of Chronic Lymphocytic Leukemia: An Italian Multicenter Case-Control StudyAlberto Fresa, Luca Laurenti, Idanna Innocenti et al.|Blood|2024Cited by 0
Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control studyAlberto Fresa, Luca Laurenti, Idanna Innocenti et al.|Blood Advances|2025Cited by 0
A landscape of genetic heterogeneity in germline predisposition to familial chronic lymphocytic leukemiaLuca Laurenti, Dimitar G. Efremov, Eugenio Sangiorgi et al.|Research Square|2025Cited by 0